<DOC>
	<DOCNO>NCT01723059</DOCNO>
	<brief_summary>Traditionally , H pylori infection treat conventional triple therapy . This include amoxicillin , clarithromycin proton pump inhibitor give daily 10-14 day . In Europe , guideline advocate treatment H pylori sequential therapy 5 day amoxicillin therapy proton pump inhibitor follow 5 day clarithromycin , metronidazole , proton pump inhibitor well response rate . We hypothesize H. pylorus resistance pattern treatment response rate observe Europe predictive resistance pattern response rate United States .</brief_summary>
	<brief_title>Standard Triple Therapy v Sequential Therapy Treatment H Pylori Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Subject sign informed consent Subject adult old 18 yr old require upper endoscopic evaluation If female child bear potential , subject negative pregnancy test nursing . Patient receive prior treatment H pylorus Subject able understand comply study procedure Recent use ( within 4 week ) medication use treatment H pylorus ( Amoxicillin , Clarithromycin , Metronidazole ) Subject undergo endoscopy acute gastrointestinal bleeding Subject allergy medication use treatment H pylorus Subject history esophageal gastric carcinoma include lymphoma Subject esophageal varix undergo endoscopy esophageal band Subject take warfarin clopidogrel Subject coagulopathy precludes safe biopsy biopsy area Subject comorbidity precludes safe participation study Subject pregnant female Subject history H. pylorus infection . Patient already enrol GI Study . History UGI surgery Nissen Fundoplication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>